Vastagbélrák: vizsgálatok itt: Kína
616 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleOrgan Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 96
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06209099 - No phaseNot yet taking people in KínaTherapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
- Where
- Xi'an
- Életkor
- 18 év to 80 év
- People
- 20
- Run by
- Xijing Hospital
See details and how to joinNCT07014254 - 2. fázisNot yet taking people in KínaIparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis
- Where
- Beijing
- Életkor
- 18 év to 79 év
- People
- 54
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07007728 - 2. fázisNot yet taking people in KínaQL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 22
- Run by
- Qianfoshan Hospital
See details and how to joinNCT07009145 - 1. fázisTaking peopleA Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 318
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT05740956 - No phaseTaking peopleExploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 55
- Run by
- Liu Huang
See details and how to joinNCT06413212 - 2. fázisTaking peoplePhase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 40
- Run by
- Fudan University
See details and how to joinNCT07003022 - 1/2. fázisTaking peopleAK129 Combination Therapy for Advanced Solid Tumors
- Where
- Shenyang
- Életkor
- 18 év to 75 év
- People
- 230
- Run by
- Akeso
See details and how to joinNCT06943820 - 2. fázisNot yet taking people in KínaA Study of Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 42
- Run by
- Tao Zhang
See details and how to joinNCT07000305 - No phaseTaking peopleThe Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients
- Where
- Guangzhou
- Életkor
- 18 év to 100 év
- People
- 327
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06998745 - 2. fázisNot yet taking people in KínaRimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 20
- Run by
- Fudan University
See details and how to joinNCT06999252 - 2. fázisTaking peopleFOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 194
- Run by
- Sun Yat-sen University
See details and how to joinNCT05727163 - 3. fázisTaking peopleLocalized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 117
- Run by
- Sun Yat-sen University
See details and how to joinNCT06208371 - No phaseNot yet taking people in KínaEarly Diagnosis and Recurrence Monitoring of Colorectal Cancer
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 1200
- Run by
- Huashan Hospital
See details and how to joinNCT06991452 - 3. fázisTaking peopleTrifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 302
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06992648 - No phaseNot yet taking people in KínaEfficacy and Safety of Robot-assisted Endoscopic Submucosal Dissection for Colorectal Neoplasm
- Where
- Jinan
- Életkor
- 18 év to 85 év
- People
- 104
- Run by
- Shandong University
See details and how to joinNCT06973083 - 2. fázisTaking peopleA Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer
- Where
- Changchun
- Életkor
- 18 év to 75 év
- People
- 46
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT06979908 - 1/2. fázisTaking peopleGlumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 42
- Run by
- Liu Huang
See details and how to joinNCT06980532 - No phaseNot yet taking people in KínaThe Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
- Where
- Kunming
- Életkor
- 18 év to 90 év
- People
- 150
- Run by
- Yunnan Cancer Hospital
See details and how to joinNCT06977373 - No phaseTaking peopleMRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
- Where
- Shenyang
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Shengjing Hospital
See details and how to joinNCT06208397 - 3. fázisTaking peopleBovine Reinforcement in Stomach, Colorectal and Lung Operation
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 172
- Run by
- Shanghai Cingularbio Co. Ltd
See details and how to joinNCT06968221 - 2. fázisNot yet taking people in KínaSintilimab Plus Bevacizumab and Chemotherapy in MSS/pMMR Colorectal With no Liver Metastasis
- Where
- Hefei
- Életkor
- 18 év and over
- People
- 20
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT06973343 - 1. fázisTaking peopleA Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 122
- Run by
- HC Biopharma Inc.
See details and how to joinNCT06307925 - 1. fázisNot yet taking people in KínaA Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
- Where
- Hangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 762
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06963502 - 4. fázisTaking peoplePrevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
- Where
- Changzhou, Hangzhou, Harbin, Nanjing, Ningbo, Shanghai, Yangzhou
- Életkor
- 18 év and over
- People
- 756
- Run by
- Fudan University
See details and how to joinNCT06090994